Does Clinical Response Correlate With Serum Certolizumab Levels?

Clinical trial NCT02597829 · UNKNOWN

Trial details

NCT number: NCT02597829
Sponsor: Shafran Gastroenterology Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2015-11-01
Primary completion: 2018-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.